Skip to Page Content


CME/CE Expiration Date: 10/9/2023*
*The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.


Description: The Pediatric Endocrine Bundle features education on complex endocrine disorders and complications associated with obesity, including polycystic ovarian syndrome (PCOS), dyslipidemia, and hypothalamic obesity. These sessions review assessment and evaluation strategies as well as evidence-based treatment modalities for diagnosing and individualizing treatment for these conditions in pediatric patients with obesity.


The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Obesity Medicine Association designates this enduring material for a maximum of 4.25 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Presentation Information
Presentation Date:
October 09, 2020
Expiration Date:
October 08, 2023 11:55 PM
Diagnosis and Treatment of Polycystic Ovarian Syndrome in Adolescent Girls

Polycystic ovarian syndrome is a common obesity-associated endocrinopathy in adolescent girls. In this session, we will discuss challenges associated with making the diagnosis of PCOS in adolescent girls based on current criteria and review common pitfalls in testing. Additionally, participants will develop an individualized treatment plan that specifically addresses the concerns of an adolescent girl diagnosed with PCOS.

  • Discuss challenges associated with current criteria for the diagnosis of PCOS in adolescent girls.
  • Recognize common pitfalls in the diagnostic laboratory testing for PCOS in adolescent girls.
  • Develop an individualized treatment plan to address the concerns of an adolescent girl with PCOS.
Pediatric Dyslipidemia

With the epidemic of childhood obesity, pediatric practitioners are required to provide appropriate management of dyslipidemia that includes testing, assessing risk, and providing treatment. Multiple metabolic comorbities such as insulin resistance, metabolic syndrome, diabetes, and hypertension complicate dyslipidemia prevalent in children and adolescents with obesity. This talk will discuss the management approach to the spectrum of dyslipidemia seen in children with obesity.

  • Discuss an overview of dyslipidemia in children with obesity
  • Assess elevated low-density lipoprotein cholesterol levels
  • Review the management strategies for elevated triglycerides
  • Evaluate mixed dyslipidemia in children and adolescents
Pharmacotherapy in Pediatric Obesity

The prevalence of pediatric obesity, especially severe obesity continues to rise particularly among minority groups. The treatment of pediatric obesity is crucial as it have severe metabolic and psychosocial consequences. The current common approach of treatment of pediatric obesity with only lifestyle and behavioral intervention has only modest benefits. Knowledge and utilization of the benefits of anti-obesity medications in children will help improve outcomes of pediatric obesity.

  • Understand the rationale for the use of pharmacotherapy in pediatric obesity
  • Discuss the available pediatric data of the commonly used weight loss medications in adults
  • Discuss the challenges in the use of these medications in children
Hypothalamic Obesity in Children and Adolescents
Motivational Interviewing and Pediatric Obesity: Clinical Conversations about Behavior Change

This session will provide an overview of motivational interviewing and its application to pediatric obesity. Dr. Bean will emphasize both the spirit of motivational interviewing as well as practical skills-based content that providers can apply to their interactions with pediatric patients with obesity.

  • Identify the spirit of motivational interviewing, and how this empirically supported treatment differs from the traditional medical paradigm.
  • Verbalize the core skills used in motivational interviewing.
  • Identify areas in clinical practice where motivational can be effective to enhance patient outcomes and improve provider satisfaction.
Pediatric Endocrine Panel
Individual topic purchase: Selected
Obesity Medicine Association
AMA PRA Category 1 Credit(s)™: 4.25
Participation Credit(s): 4.25
Share This
All Access Subscription
Use for All Access  account holders only
To continue, you need to log in to oma. If you have any questions about your account please contact us at 1-866-702-3278.
Email Address:
Streaming + MP4 Download
OMA Member Price:
Non Member Price: Become a Member!   $102.00